N-6 dimethylaminopurine (6DMAP) has been shown to induce aberrant mitosis in different cell types including Chinese hamster fibroblasts (CHEF/18). The mechanism of action and the cellular targets, however, are still not clear. We showed previously that in CHEF/18 cells this compound inhibits DNA synthesis with a kinetic of inhibition suggestive of an effect on early events of the cell cycle. In this paper we investigated which cellular targets were affected by 6DMAP and found that: (i) the compound inhibits phosphorylation of ribosomal protein S6 and activation of the 70 kDa S6 kinase (p70 S6k ) known to be activated by epidermal growth factor (EGF) in keeping with the notion that it is a protein kinase inhibitor; however the inhibition in vivo appears to be specific as MAP kinase phosphorylation is not inhibited; (ii) 6DMAP drastically affects cytoskeletal components leading to a rapid morphological change in most cells. These data, together with the findings that the dose range and the treatment time effective in inducing the micronuclei containing chromosomes were the same as for DNA synthesis inhibition, suggest that a disturbance in G, of signal transduction pathways may contribute to abnormal mitosis.
Introduction
It has been proposed that alkylation of the nucleotide pool may be the mechanism by which alkylating agents induce chromosome loss (Abbondandolo et al, 1993) . Indeed, addition of O 6 alkylated purines to the medium at subtoxic concentrations induce aneuploidy in cultured cells (Abbondandolo et al, 1989) . Since these alkylated purines are not incorporated in the DNA (Ball et al, 1983 ) they must exert their effects through other cellular components.
We have recently studied the effect of a series of alkylated purines on different phases of the cell cycle in Chinese hamster fibroblasts (Simili et al, 1995) . These cells, synchronized in G o by serum starvation, can be induced to undergo one round of DNA synthesis and mitosis after addition of appropriate growth factors (Simili et al, 1994) .
Our results showed that all tested O 6 alkylated purines affect DNA synthesis as well as mitosis (Simili et al, 1995) . Inhibition of DNA synthesis by one of these purine analogues, N-6 dimethylaminopurine (6DMAP), was more pronounced when the compound was given during early Gj, suggesting an interference with early biochemical events © UK Environmental Mutagen Society/Oxford University Press 1997 responsible for the Gi/S transition. Interestingly the kinetic experiments of induction of abnormal mitosis showed that 6DMAP induces the same amount of aberrant mitotic figures when present during G/S as when present in G 2 /M phases; while a continuous presence of 6DMAP during the whole cell cycle induced mitotic abnormalities which approached the sum of the two treatments. These findings raised the possibility that different targets might be affected in different phases of the cell cycle, some of which are present in G) and others in M phase.
Recently it has been found that alteration of ras-MAP kinase signal transduction pathway induces chromosome instability (Denko et al, 1995; Miranda et al, 1996) , so it is possible that in CHEF/18 cells a disturbance in early events of the cell cycle (possibly also causing DNA synthesis inhibition), might contribute to aberrant mitoses, or that aberrant DNA synthesis per se might induce abnormal mitoses. Protein kinases important in cell cycle control could be other possible targets. In vivo interference with protein kinase activity by 6DMAP is likely as an aspecific inhibition in vitro has been shown (Vesely et al, 1994) . Since 6DMAP has been shown to act as a non-specific kinase inhibitor in vitro it is expected to interfere with protein kinase activity in vivo. However, the in vivo targets have yet to be identified. Studies carried out with mammalian cells have shown that 6DMAP overrides the cell cycle check points, possibly by interfering with the activation of protein kinases important for cell cycle regulation such as p34 cdc2 (Schelegel et al, 1990; Steinmann et al, 1991) . However most of these studies have been carried out using high concentrations of this adenine analogue, which at such concentrations is known to induce toxic effects (Debatisse et al, 1981) , and using synchronizing agents which might alter the levels of cyclins (Urbani et al, 1995) . In this study we have evaluated the effect of 6DMAP on protein kinases activation believed to be important in the Gj/S and G 2 /M transitions of the cell cycle, avoiding toxic concentrations and synchronizing agents.
In Chinese hamster fibroblasts, as in many other cell lines, growth factors activate two independent signal transduction pathways: the ras-raf MAP kinase pathway (Meloche et al, 1992; Kahan et al, 1992) and the p70 S6k pathway (Susa et al, 1989) , which appear to be essential to proceed towards DNA synthesis (Ming et al, 1994; Meloche, 1995) .
In mammalian cells MAP kinase is known to be a regulatory enzyme not only in G f /G! (Meloche, 1995) but also in G2/M at least in mouse oocytes (Verlhac et al, 1993) . Recently, reactivation of MAP kinase during late mitosis has been found in mouse fibroblasts (Edelmann et al, 1996) .
For these reasons we asked if either one of these pathways was affected by 6DMAP and found that p70
S6k was inhibited while MAP kinase was not. As 6DMAP affected cell shape in CHEF/18 cells, a study on cytoskeleton was also undertaken as the cytoskeleton is an obvious target in the G2/M phase. Our results indicate that intermediate filaments, microtubules and actin filaments were affected; however, no gross alteration of (3-tubulin polymerization could be found.
Materials and methods

Cell cultures
Diploid Chinese hamster embryo fibroblasts CHEF/18 cells, kindly provided by Professor R.Sager (Dana Farber Cancer Institute. Boston. MA, USA) were routinely grown in an atmosphere of 10% COT at 37°C in an incubator, and at a density of 2X10 4 cells/cm 2 in cx-minimal essential medium (aMEM: Gibco, Grand Island. NY) supplemented with 10% fetal calf serum (FCS: ICN Laboratories, Amsterdam, The Netherlands). All experiments were performed with CHEF/18 cells at early passages (10-20th) in order to minimize the variability of the cells response to growth factors (Cherrington and Pardee, 1980) . DNA synthesis CHEF/18 cells were plated at a density of 1 X 10 4 cells/cm 2 in 35 mm 2 dishes containing 2 ml of medium. After one medium change on the third day of culture, cells were taken to quiescence on the 6th day by replacing the growth medium with serum-free medium. After 24 h cells were quiescent as judged by cell number and proportion of labelled nuclei (Simili et ah, 1994) . EGF (20 ng/ml). insulin (1 ng/ml) and other compounds were added at the indicated limes, together with [ 3 H]thymidine (1 mCi/ml; Amersham) and DNA synthesis determined 24 h after addition of growth factors, as the amount of radioactivity incorporated into trichloroacetic acid (TCA)-precipitable material (Simili el al.. 1995) . The percentage of DNA synthesis was calculated considering as 100% the DNA synthesis obtained in cultures treated with EGF plus insulin for 24 h. In most experiments 6DMAP and other compounds were added to the medium al the same time (to) as growth factors, EGF and insulin.
Growth factors and other chemicals
Micronucleus assay
The micronucleus assay was carried out as follows: plates (quadriperm; Heraeus, Osterode, Germany) containing four slides each were seeded with 10 5 cells/plate 16 h before treatment. For each assay, at least two independent experiments were carried out. 6DMAP and other compounds were added to the culture medium and left until fixation times (24 h). Slides with attached cells were treated with a mildly hypotonic solution (Bonatti el al.. 1983) for 10 min and fixed with cold methanol. To discriminate between micronuclei with or without kinetochores indicative of the presence of chromosomes or fragments, immunostaining with CREST antiserum (Antibodies Inc.. Davis. CA) was performed as described by Niisse et al. (1989) .
Analysis of chromosome displacement
Cultures were maintained at 37°C and not subjected to metaphase block/or hypotonic treatment. The analysis was carried out in metaphase, anaphase and telophase (Bonatti et al.. 1986 ). The medium was removed from plates at the fixation times, cells were washed twice which phosphate-buffered saline (PBS) at 37°C, fixed with methanol-acetic acid (3:1) and stained with Giemsa.
Determination of ribosomal S6 phosphorylation
Isolation of ribosomes from quiescent cells was performed according to the method of Krieg et al. (1988) . Ribosomes were resuspended in Laemmli sample buffer containing 6 M urea (Laemmli, 1970) . Electrophoretic transfer from gel to nitrocellulose and immunoperoxidase staining of protein blots were performed as described (Nielsen et al., 1982) utilizing the monoclonal antibody against S6 kindly provided by Dr H.Towbin (CIBA Geigy. Basel. Switzerland). The second antibody [peroxidase-conjugated rabbit anti mouse immunoglobulin (Ig)G] was from Dako (Glostrup. Denmark).
Methods of protein determination
Protein concentration of cell extracts was measured using a BioRad (SegrateMilano. Italy) protein assay kit with bovine serum albumin as standard.
In vitro S6 kinase assay
Extracts and 40 S ribosomal subunit were prepared according to Han et al. (1995) . Cell extracts diluted 1:10 (-6 p.g/assay) were mixed with an equal volume of S6 kinase buffer, 40 S ribosomal subunits (2 mg/ml) and protein kinase inhibitor peptide (PKJ: Sigma) 0.5 11M in 0.005% bovine serum albumin, 0.3 ml [y-^2P]ATP (20 mCi/ml) at 37°C for 30 min. as previously described (Han et al, 1995) . The reaction was stopped with Laemmli sample buffer, boiled at 95°C, centrifuged and loaded onto sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) gel S6 phosphorylation was visualized by autoradiography.
MAP kinase phosphorylation
For determination of MAP kinase phosphorylation extracts were prepared as described by Yin et al. (1992) . After electrophoresis proteins were blotted on Hybond nitrocellulose (Amersham) and MAP kinase detected with monoclonal antibody (ICN Laboratories) which recognizes the two isoforms of 44 and 42 kDa molecular weight. To amplify the signal the chemiluminescence (ECL) method of Amersham was used.
Immunostaining of cytoskeletal components
Cells were plated at concentration of 1.5xl0 4 /ml onto round coverslips in a 24-well tissue culture plate. Semiconfluent cells treated with fresh medium without serum for 20 h were stimulated by growth factors with or without 6DMAP and fixed at different times after treatment.
For P-tubulin and vimentin cells were washed in PBS and then fixed with methanol-acetone (1:1) for 15 min at -20°C; for actin cells were fixed for 30 min in paraformaldeyde 3% at room temperature followed by incubation with methanol-acetone (1:1) at -20°C. Cells were then washed in PBS and blocked in 10% rabbit serum (Boehringer) and monoclonal antibodies (fi-tubulin and vimentin. Boehringer; and actin, ICN) diluted 1:50 were applied for 1 h. Cells were then treated with the second antibody [fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse; Sigma] diluted 1:50 and coverslips were mounted onto a slide with a drop of Dabco solution.
Results
We have previously shown that 6DMAP, at subtoxic concentrations (0.5 mM), inhibits DNA synthesis stimulated by growth factors and induces aberrant metaphases in CHEF/18 cells (Simili et al., 1995) . In this paper we investigate whether the dose range required to inhibit DNA synthesis is the same as that required to induce chromosome malsegregation. To verify this point, CHEF/18 cells were treated with different concentrations of 6DMAP, and both chromosome malsegregation and inhibition of DNA synthesis were evaluated after 24 h in EGF + insulin-stimulated cells. Adenine was used to control the effect of a normal base on both parameters. Table I shows the induction of micronuclei with different doses of 6DMAP and adenine; it is evident that the increase is due to micronuclei containing kinetochores. Figure 1 shows the results of DNA synthesis inhibition after 24 h of treatment. Adenine in the dose range used (0.05-0.5 mM) has no detectable effect on either DNA synthesis or micronuclei induction while 6DMAP is maximally effective in both cases at 0.5 mM. Doses >0.5 mM induce extensive apoptosis (data not shown).
Effect of 6DMAP on signal trasduction pathway
The kinetic of DNA synthesis inhibition by 6DMAP indicated that this compound affected some early events taking place within a few hours after addition of growth factors (Simili et al., 1995) . It is known that after EGF binding to the receptor a series of transducing molecules and protein kinases are activated which, in the end, lead to mRNA and protein synthesis. One of the earliest biochemical event triggered by growth factors is phosphorylation of the ribosomal protein S6 (Thomas et al., 1982) . We have shown that in quiescent CHEF/ 18 cells treated with EGF, S6 is transiently phosphorylated (with the maximun phosphorylation at 30 min) and compounds which inhibit DNA synthesis also inhibit this phosphorylation (Simili et al., 1994) . In agreement with these findings recently we have shown that alkylated purines such as O pre-treated with 0.5 mM there was a marked inhibition of S6 phosphorylation both at 30 min and at 1 h as indicated by the almost total disappearance of the upper band (Figure 2) . After 3 h of EGF treatment 6DMAP inhibition is still evident although less appreciable as S6 phosphorylation is barely detectable (Figure 2, lanes 1 and 2) . In most somatic cells, a specific protein kinase, the p70 S6k (Stewart et al, 1994) , is responsible for the phosphorylation of ribosomal S6 and inhibition of this enzyme has been found to inhibit DNA synthesis (Lane et al, 1993) . For this reason we studied the effect of 6DMAP on pTO 561 ' activity in CHEF/18 cells stimulated by growth factors. Rapamycin, a powerful and specific inhibitor of this protein kinase, was also used as positive control (Pearson et al, 1995) . In Figure 3 , the activity of p7QS6k j s reported 45 min after EGF addition with or without inhibitors. 6DMAP provoked an inhibition of kinase activity, even if to a lesser extent than the specific inhibitor, rapamycin.
MAP kinase is considered to be a key enzyme of the ras-raf signal transduction pathway and according to certain authors could play a role both in early Gj-»S transition and M phase (Verlhac et al, 1993; Edelmann et al, 1996) . For these reasons it was interesting to see the effect of 6DMAP on the activation of MAP kinase in CHEF/18 cells stimulated with EGF. Quiescent CHEF/18 cells were pre-treated with 6DMAP before EGF addition, and extracts were made at different times according to the procedure described in methods. MAP kinase activation was evaluated by determining the mobility shift of the band due to phoshorylation of the protein by MAP kinase (Yin and Yang, 1994) . As it can be seen from Figure 4 the antibody recognizes both isoforms of MAP kinase (42 and 44 kDa molecular weights). As early as 15 min after EGF treatment, the characteristic mobility shift of both isoforms due to phosphorylation of the proteins was observed. 6DMAP does not prevent the mobility shift of either bands at early or late times (up to 2 h) suggesting that the ras-raf pathway, at least up to MAP kinase is not inhibited.
Effects of 6DMAP on cytoskeletal components
One of the early effects of 6DMAP in CHEF/18 cells is a very rapid change in cell morphology; after 3 h of treatment cells lose the fibroblastic appearance and become round suggesting an effect on cytoskeletal organization ( Figure 5 ). Studies performed in mammalian cells in Xenopus oocytes indicate that the cytoskeleton plays an important role in the G|/S transition as well as G 2 /M (Nishida and Gotoh, 1992) . For this reason we have studied the effect of 6DMAP on microtubules, microfilaments and intermediate filaments by indirect immunofluorescence. The results show that in CHEF/ 18 cells in G] 6DMAP induces a rapid (3 h) disruption of the normal structure of microtubules, microfilaments and intermediate filaments (Figure 6 ) with the collapse of normal network. As microtubules are the main component of the mitotic spindle we further investigated the ability of 6DMAP to inhibit p-tubulin polymerization. The results obtained with the 'tubulin in vitro polymerization assay' (Gaskin et al, 1974) indicated that 6DMAP inhibits p-tubulin polymerization significantly only at 20 mM, while at lower concentrations it is ineffective (data not shown). Nor were we able to detect differences in the ratio of polymerized to non-polymerized p-tubulin in extracts of 6DMAP treated cells (data not shown).When we tried to analyse microtubules in mitosis with immunofluorescence we encountered difficulties due to the round phenotype of mitotic cells so the formal possibility that 316 this compound might alter tubulin polymerization in mitosis cannot be excluded although it would appear unlikely.
Effect of 6DMAP on mitosis
Indirect evidence that 6DMAP did not grossly alter spindle microtubules was obtained from a more accurate examination of aberrant mitoses in CHEF/18 cells treated with 6DMAP at different points in the cell cycle. In quiescent CHEF/18 cells stimulated by growth factors DNA synthesis starts 12-14 h after growth factor addition and metaphases appear at 20-22 h with a peak at 24-26 h (Simili et al, 1995) . Aberrant mitotic figures were classified into two classes: (i) mitoses with only few (one to three) displaced chromosomes; (ii) grossly aberrant mitoses with more than three chromosomes (Table n, first three columns). C-mitoses indicating a complete failure to form spindle were rarely observed in any conditions and the resulting multinucleated cells were rarely seen. Analysis of these data by Fisher's exact test indicated that 6DMAP when given either for 2 or 24 h does not significantly change the distribution of grossly aberrant mitoses mitoses with single displaced chromosomes, suggesting an effect of this compound on single chromosome attachment rather than on the entire spindle. These results indicate that 6DMAP provoked aberrant mitoses when present either in G] or G2-M phases (compare treatment for the first 10 h and last 2 h in Table II) . To demonstrate that induced abnormal mitoses give rise to aneuploidy we quantified the induction of micronuclei containing kinetochores in interphase cells observed 6 h after mitosis (Table II , last two columns). Our results clearly show an induction of CREST+ micronuclei after 6DMAP treatments. It has to be pointed out that with this protocol the induction of micronuclei can be underestimated as abnormal mitoses may not always give rise to two daughter cells. Moreover underestimation may change with different treatment which may slow down differently the rate of cell cycling; this could explain why the proportion of aberrant mitoses which produced CREST+ was less when 6DMAP was present in the medium during M phase (see Table II : 6DMAP 24 h and 6DMAP last 8 h). The most interesting finding in this context was the induction of CREST+ micronuclei after 10 h treatment during G,/S phase.
Discussion
We have previously found that in CHEF/18 cells, 6DMAP induces a significant number of abnormal mitoses, when present either in G,/S or G 2 /M phase, suggesting that distinct targets might be affected in different phases of the cell cycle (Simili et al, 1995) . For this reason we have investigated further the effect of this purine analogue at non-toxic concentrations on early and late targets. The kinetic of DNA synthesis inhibition indicated that the compound could interfere with the same early events of the signal transduction pathway. Interestingly we found that 0.5 mM of 6DMAP was an effective dose in inducing both DNA synthesis inhibition and chromosome malsegregation (Figure 1) .
We postulated that since 6DMAP is an inhibitor of protein kinases it could interfere with protein kinase(s) important for the transition Gj/S. As activation of p70
S6k and of MAP kinase are two early events necessary for the cell to perform DNA synthesis (Meloche et al, 1992; Ming et al, 1994) we studied the effect of this base analogue on these pathways.
Our results indicate that 6DMAP exhibits specificity of action in vivo although it appears to be an aspecific inhibitor of protein kinases in vitro (Vesely et al, 1994) since it inhibits S6 phosphorylation and p70 s6k activity but not MAP kinase phosphorylation in CHEF/18 cells. It has been reported (Mahadevan et al., 1990 ) that 2-aminopurine, a similar base analogue, blocks the phosphorylation of the nuclear protein of 33 kDa, later found to be ribosomal protein S6 in mouse fibroblasts (Mahadevan, 1993) : however, to our knowledge this is the first report of inhibition of p70 S6k pathway by 6DMAP. We have previously shown that other aneugenic alkylated bases, such as O 6 -methylguanine and <9
6
-ethylguanine induced inhibition of ribosomal S6 phosphorylation but not MAP kinase activation (Bonatti et al, 1996) . Preliminary results indicated that these analogues also inhibit the p70 S6k activity (manuscript in preparation).
Inhibition of p70 s6k correlates well with DNA synthesis inhibition as microinjection of antibody neutralizing this enzyme blocks progression of G| cells towards S phase (Lane et al, 1993) . Our results indicated that treatment with 6DMAP in Gj phase induces aberrant mitosis and micronuclei containing kinetochores (CREST+) suggesting chromosome malsegregation. At present we do not know whether the inhibition of p70
S6k is causally related to induction of aberrant mitosis. However, some hypotheses can be put forward, (i) It is known that inhibition of p70
S6k by rapamycin blocks the synthesis of specific proteins (Jefferies et al, 1994) . By analogy it is possible that 6DMAP affects protein synthesis in G) and alters the expression of proteins important for cell cycle progression, (ii) It is worth noting that some of the components of kinetochores such as CENBP are mainly produced in G, (Knehr et al, 1996) . Recently it has been suggested that p70 S6k pathway might have a role in the expression of cyclindependent kinases and it is possible that an inhibition of this pathway might also affect the mitotic process (Morice et al, 1993; Nourse et al, 1994) . It is also possible that a disturbance of DNA synthesis per se might lead to increased chromosome instability (Denko et al, 1995) ; however, if this were the case, one should find induction of CREST-micronuclei, due to chromosome fragments, which were never observed with our methods, (iii) Finally, another possibility is that 6DMAP blocks some upstream regulator of p70 S6k which may be important for proper execution of M phase. It is known that p70
S6k is, in turn, activated by multiple phosphorylations in response to mitogenic stimuli (Weng et al, 1995a) . Although the signal transduction pathway responsible for p70
S6k activation is not yet fully clarified, phosphatidyl inositol 3 kinase (PI3k) has been proposed to be a likely upstream regulator (Monfar et al, 1995; Weng et al, 1995b) and in vitro purine analogues such as SQ2006 and theofilline were shown to inhibit this enzyme (Petrich et al, 1996) . It is worth mentioning that PI3k is homologous to a family of protein kinases among which the product of the gene defective in Ataxia Telengectasia, a disease characterized by high radiation sensitivity and spontaneous chromosome malseeregation (Savitsky et al. 1995 : Shiloh. 1995 .
The kinetic of aberrant mitoses induction shows clearly that 6DMAP induces a significant amount of aberrant mitoses even when given during the G 2 /M phase. Whether the effect of the base analogue in M phase is due to inhibition of specific kinases remains to be determined; however, the p70
S6k is unlikely to be involved as the enzyme shows very low activity in this phase (Edelman et al. 1996) . The effect of 6DMAP on cell shape was indicative of interference with cytoskeleton. a possible G 2 /M target, and our results showed a marked reorganization of all three main cytoskeletal components following treatment with 6DMAP. We cannot distinguish which structure collapses first and is responsible for the reorganization of the others (Escribano et al, 1988) ; however, as 6DMAP (0.5 mM) does not appear to alter the polymerization of fi-tubulin either in vitro or in extracts, it is possible that changes in actin and cell shape might induce microtubule collapse (Lamb et al, 1990) . At present we cannot rule out the possibility that the effect of 6DMAP on the cytoskeleton might impair the function of the spindle microtubules at mitosis and cause displaced chromosomes. The fact that 6DMAP in M phase does not appear to induce micronuclei may be due to a mitotic delay, an effect already described in CHEF/18 cells (Simili et al, 1995) and other cell lines (Niklas et al, 1993) , which will lead to an underestimation of the micronuclei observed at interphase.
In summary, 6DMAP appears to act in different phases of the cell cycle possibly through different targets: interestingly our results indicate that treatment in G] specifically inhibits the p70
S6k signalling pathway and induces chromosome malsegregation suggesting that an alteration of early events responsible for the transition G(/G| may contribute to abnormal mitosis.
